Dr Roxanne Marcillle, MD | |
2113 Adams Grove Road, Suite 210, Columbia, RI 29203 | |
(803) 748-7555 | |
(803) 748-9555 |
Full Name | Dr Roxanne Marcillle |
---|---|
Gender | Female |
Speciality | Pediatrics - Pediatric Pulmonology |
Location | 2113 Adams Grove Road, Suite 210, Columbia, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780644963 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0214X | Pediatrics - Pediatric Pulmonology | 12947 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Roxanne Marcillle, MD 2113 Adams Grove Road, Suite 210, Columbia, RI 29203 Ph: (803) 748-7555 | Dr Roxanne Marcillle, MD 2113 Adams Grove Road, Suite 210, Columbia, RI 29203 Ph: (803) 748-7555 |
News Archive
Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company's semiconductor-based synthetic gene manufacturing process.
The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover - the skin, nails, bone marrow, lungs and gut. Patients with DKC experience life-threatening symptoms. Bone marrow failure increases their risk of fatal infections and cancer. Many die before the age of 30 and management of the disease is limited to trying to treat its symptoms.
The Associated Press: "When Congress battles over thorny bills, parliamentarian Alan Frumin has been known to sleep in his office — on call 24/7 as the Senate's Solomon, divining the answers. Frumin's ability to review long-standing rules and centuries of precedent to resolve Senate questions makes the mustachioed parliamentarian something of a Washington rock star these days.
Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.
Scientists are now saying that women who take the birth control pill could be increasing their risk of cervical and breast cancer.
› Verified 6 days ago